Covid-19 Impact on Infectious Disease Diagnostics Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infectious Disease Diagnostics Industry
1.7 COVID-19 Impact: Infectious Disease Diagnostics Market Trends
2 Global Infectious Disease Diagnostics Quarterly Market Size Analysis
2.1 Infectious Disease Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infectious Disease Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Infectious Disease Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Infectious Disease Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Infectious Disease Diagnostics Market
3.4 Key Players Infectious Disease Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Infectious Disease Diagnostics Segments, By Type
4.1 Introduction
1.4.1 Molecular Diagnostic Technique
1.4.2 Traditional Diagnostic Technique
4.2 By Type, Global Infectious Disease Diagnostics Market Size, 2019-2021
5 Impact of Covid-19 on Infectious Disease Diagnostics Segments, By Application
5.1 Overview
5.5.1 Hepatitis C
5.5.2 Hepatitis B
5.5.3 Tuberculosis (TB)
5.5.4 Acquired Immunodeficiency Syndrome (AIDS)
5.5.5 Human Papillomavirus (HPV)
5.5.6 Methicillin-resistant Staphylococcus Aureus (MRSA)
5.2 By Application, Global Infectious Disease Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Infectious Disease Diagnostics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Bio Mérieux SA
7.1.1 Bio Mérieux SA Business Overview
7.1.2 Bio Mérieux SA Infectious Disease Diagnostics Quarterly Revenue, 2020
7.1.3 Bio Mérieux SA Infectious Disease Diagnostics Product Introduction
7.1.4 Bio Mérieux SA Response to COVID-19 and Related Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Business Overview
7.2.2 Roche Diagnostics Infectious Disease Diagnostics Quarterly Revenue, 2020
7.2.3 Roche Diagnostics Infectious Disease Diagnostics Product Introduction
7.2.4 Roche Diagnostics Response to COVID-19 and Related Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Business Overview
7.3.2 Abbott Laboratories Infectious Disease Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Laboratories Infectious Disease Diagnostics Product Introduction
7.3.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.4 Thermo Fischer Scientific
7.4.1 Thermo Fischer Scientific Business Overview
7.4.2 Thermo Fischer Scientific Infectious Disease Diagnostics Quarterly Revenue, 2020
7.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Product Introduction
7.4.4 Thermo Fischer Scientific Response to COVID-19 and Related Developments
7.5 BD
7.5.1 BD Business Overview
7.5.2 BD Infectious Disease Diagnostics Quarterly Revenue, 2020
7.5.3 BD Infectious Disease Diagnostics Product Introduction
7.5.4 BD Response to COVID-19 and Related Developments
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Business Overview
7.6.2 Bio-Rad Laboratories Infectious Disease Diagnostics Quarterly Revenue, 2020
7.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Product Introduction
7.6.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.7 Abbott
7.7.1 Abbott Business Overview
7.7.2 Abbott Infectious Disease Diagnostics Quarterly Revenue, 2020
7.7.3 Abbott Infectious Disease Diagnostics Product Introduction
7.7.4 Abbott Response to COVID-19 and Related Developments
7.8 Danaher
7.8.1 Danaher Business Overview
7.8.2 Danaher Infectious Disease Diagnostics Quarterly Revenue, 2020
7.8.3 Danaher Infectious Disease Diagnostics Product Introduction
7.8.4 Danaher Response to COVID-19 and Related Developments
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Business Overview
7.9.2 Johnson and Johnson Infectious Disease Diagnostics Quarterly Revenue, 2020
7.9.3 Johnson and Johnson Infectious Disease Diagnostics Product Introduction
7.9.4 Johnson and Johnson Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infectious Disease Diagnostics Assessment
Table 9. COVID-19 Impact: Infectious Disease Diagnostics Market Trends
Table 10. COVID-19 Impact Global Infectious Disease Diagnostics Market Size
Table 11. Global Infectious Disease Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Infectious Disease Diagnostics Market Growth Drivers
Table 14. Global Infectious Disease Diagnostics Market Restraints
Table 15. Global Infectious Disease Diagnostics Market Opportunities
Table 16. Global Infectious Disease Diagnostics Market Challenges
Table 17. By Players, Infectious Disease Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Infectious Disease Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Infectious Disease Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Infectious Disease Diagnostics Market
Table 21. Key Players Infectious Disease Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Infectious Disease Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Infectious Disease Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Infectious Disease Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Bio Mérieux SA Business Overview
Table 58. Bio Mérieux SA Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bio Mérieux SA Infectious Disease Diagnostics Product
Table 60. Bio Mérieux SA Response to COVID-19 and Related Developments
Table 61. Roche Diagnostics Business Overview
Table 62. Roche Diagnostics Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Diagnostics Infectious Disease Diagnostics Product
Table 64. Roche Diagnostics Response to COVID-19 and Related Developments
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Laboratories Infectious Disease Diagnostics Product
Table 68. Abbott Laboratories Response to COVID-19 and Related Developments
Table 69. Thermo Fischer Scientific Business Overview
Table 70. Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Thermo Fischer Scientific Infectious Disease Diagnostics Product
Table 72. Thermo Fischer Scientific Response to COVID-19 and Related Developments
Table 73. BD Business Overview
Table 74. BD Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. BD Infectious Disease Diagnostics Product
Table 76. BD Response to COVID-19 and Related Developments
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bio-Rad Laboratories Infectious Disease Diagnostics Product
Table 80. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 81. Abbott Business Overview
Table 82. Abbott Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Abbott Infectious Disease Diagnostics Product
Table 84. Abbott Response to COVID-19 and Related Developments
Table 85. Danaher Business Overview
Table 86. Danaher Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Danaher Infectious Disease Diagnostics Product
Table 88. Danaher Response to COVID-19 and Related Developments
Table 89. Johnson and Johnson Business Overview
Table 90. Johnson and Johnson Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Johnson and Johnson Infectious Disease Diagnostics Product
Table 92. Johnson and Johnson Response to COVID-19 and Related Developments
List of FiguresFigure 1. Infectious Disease Diagnostics Product Picture
Figure 2. Infectious Disease Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infectious Disease Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infectious Disease Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infectious Disease Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infectious Disease Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infectious Disease Diagnostics Market Size Market Share, 2019-2021